Cell Bio Human TechLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Cell Bio Human TechLtd has a total shareholder equity of ₩44.1B and total debt of ₩5.8B, which brings its debt-to-equity ratio to 13.2%. Its total assets and total liabilities are ₩52.4B and ₩8.2B respectively. Cell Bio Human TechLtd's EBIT is ₩3.3B making its interest coverage ratio -419.3. It has cash and short-term investments of ₩16.8B.
Belangrijke informatie
13.2%
Verhouding schuld/eigen vermogen
₩5.82b
Schuld
| Rente dekkingsratio | -419.3x |
| Contant | ₩16.77b |
| Aandelen | ₩44.13b |
| Totaal verplichtingen | ₩8.22b |
| Totaal activa | ₩52.35b |
Analyse van de financiële positie
Kortlopende schulden: A318160's short term assets (₩25.9B) exceed its short term liabilities (₩8.0B).
Langlopende schulden: A318160's short term assets (₩25.9B) exceed its long term liabilities (₩234.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: A318160 has more cash than its total debt.
Schuld verminderen: A318160's debt to equity ratio has increased from 0.7% to 13.2% over the past 5 years.
Schuldendekking: A318160's debt is well covered by operating cash flow (123.6%).
Rentedekking: A318160 earns more interest than it pays, so coverage of interest payments is not a concern.